FDA Proposes Amendment to Clinical Hold Regulations for Life-Threatening Diseases

Summary

The FDA is proposing to relax its rules for clinical trials involving life-threatening diseases, allowing women with reproductive potential to participate in studies that may pose a risk to their fertility, in an effort to ensure they are not automatically excluded from trials in the future.